EMORY UNIVERSITY HOSPITAL

Customer ID: 14300

Edit Customer Back to Customers
Customer Information

Not specified

Not specified

Unknown

Not specified

Andrew

10/10

$0.00

August 2025

Activity Summary

September 18, 2025

Not scheduled


10

Activities

1

Quotes
AI Insights
LLM-generated; verify before action. Refresh
Health 10/10 Last contact Sep 18, 2025 10 activities 1 quotes 1 QBRs
Insights
  • Health score is perfect at 10/10, indicating strong customer satisfaction.
  • All recent activities have been proactive, with multiple emails and a follow-up.
  • Account manager Andrew is actively engaged with the account.
Risks
⚠️The customer value is currently at 0.0, indicating no revenue generation.
⚠️Recent quote was rejected, leading to a 0% win rate.
Opportunities
📈Potential to convert follow-up activities into successful deals.
📈Opportunity for account manager to explore new strategies to secure future wins.
Contacts
DAVID TROY

PURCHASING

troy.david@emoryhealthcare.org

(404) 686-5034

KAYLA GINN

END USER

kayla.ginn@emoryhealthcare.org

(404) 712-3856

WILLA ZHANG

LAB END USER

WILLA.ZHANG@EMORYHEALTHCARE.ORG

404-686-5876

Recent Activities
Log Activity
quote 5733 follow up- Rejection and reason
Email Completed Lost Opportunity
2025-09-18 14:58
View Edit
Hi Willa, Thanks for this update! We are standing by to support, just let us know when the time is right. Have a Great Day, Andrew Hartmann Business Development Manager – 25020 Avenue Tib...
QUote 5733 follow up
Email Completed
2025-09-18 13:43
View Edit
Thanks for the update Willa! Let me know how I can be of support. Do you have an estimate when you may be looking to make this change? It will help me know when is best to follow up with you on t...
Matrix confirmation for Busulfan quote
Email Completed
2025-09-17 19:13
View Edit
Thanks for confirming Willa, Our team will get this quote updated and send it back your way, likely a little later today. Regards, Andrew Hartmann Business Development Manager – 25020 Aven...
Quote requested coming out of QBR conversation
Email Completed Quote Requested
2025-09-17 14:51
View Edit
Hi Willa, Confirming this has been received and sent to our team for processing. We will reach back out if we have any follow up questions, otherwise you should get this quote in the next 1-3 days...
Sending email to try and get details to quote buslufan QC
Follow-up Completed
2025-09-16 15:35
View Edit
Hi Willa, Thank you so much for your time on the call and sharing your valuable feedback. We really appreciate you! To get a quote for a busulfan QC we just need replies to the following question...
QBR completed
Call Completed
2025-09-16 15:27
View Edit
QBR Emory and UTAK Introduction and account management changes @ 1:00 Andrew Hartmann from UTAK Laboratories introduces himself as the new account manager for Emory. He explains that UTAK is makin...
QBR scheduled, customer prefers telephone call
Email Completed
2025-09-16 14:27
View Edit
Hi Willa, Thanks for the update! I’ll give you a call in about a ½ hour at 11 your time today. I look forward to connecting with you. Regards,
QBR schedule follow up
Email Completed Due Sep 24, 2025
2025-09-10 16:02
View Edit
Hi Team Emory, I wanted to circle back on this request as we are eager to get some feedback from your team, as well as ensure we are aligned to meet your needs for the future. Can you please use t...
Scheduling Our Quarterly Business Review (CID:014300)
Email Completed Due Sep 11, 2025 Needs Follow-up
2025-09-02 20:59
View Edit
Hi Team Emory, Zhang, Huizhen <willa.zhang@emoryhealthcare.org>; Ginn, Kayla Brooke <kayla.ginn@emoryhealthcare.org>; David, Troy Delaney <troy.david@emoryhealthcare.org> I hope you’re doing well! It...
UTAK open quote follow up - Quote #5307
Email Completed Relationship Building
2025-08-22 16:48
View Edit
I hope summer is treating you well. I wanted to touch base and see if you have everything you need from UTAK. I see your team has been using a few of our products for more than a decade now. We wou...
Quote # Amount Status Confidence Date Valid Until Intelligence Actions
5733 $10673.00 Rejected 2025-09-17 2025-12-16
Quarter Scheduled Status Completed Customer Sat
Q3 2025 AH 2025-09-16 Completed 2025-09-16 10 Edit